Download Content

Chemically-Modified Polynucleotides for Inhibiting, Expressing & Repairing Nucleic Acids: Then & Now

Please enter your details into the form below to access the Webinar on ‘Chemically-Modified Polynucleotides for Inhibiting, Expressing & Repairing Nucleic Acids: Then & Now‘ hosted by Tod Woolf, Founder & CEO, ETAGEN Pharma, Inc.